The first International Brain Health Conference took place in Edinburgh on 18-19 May 2026. With a theme of Advancing Brain Health, IBHC2026 brought together international leaders to explore the latest advances in understanding brain health and its role in preventing neurodegenerative disease.

200 attendees from the life sciences and pharmaceutical industry, academia, policy and healthcare industry attended to listen to presentations, network and learn about developments from sponsors and partners.

Through the lenses of public health, personalised medicine, and early detection, the conference examined emerging tools, biomarkers, and service models that enable earlier, more effective intervention and support brain health across the life course.

Watch the highlights video to get a flavour of the International Brain Health Conference 2026.

More news

Lecanemab is approved by MHRA in Great Britain, and restricted in NHS

Following today's announcements from the MHRA and NICE about a new drug, lecanemab - which approve its use in Great Britain, but block its adoption in NHS England - our CEO and Founder, Prof Craig Ritchie has responded.

Deputy First Minister announces Scottish Brain Sciences as anchor tenant in ONE BioHub Aberdeen

Our CEO, Prof Craig Ritchie, and Chair, Mark Cook, were delighted to meet with Deputy First Minister,Kate Forbes MSP, at our new base in ONE Biohub in Aberdeen.

New Alzheimer’s Vaccine Trial in Scotland

Scottish Brain Sciences is delighted to be the first clinical site open in the UK & Europe, to deliver a clinical trial of a new active immunotherapy (a vaccine) aimed at preventing or slowing the progression of Alzheimer's Disease.